Home > Income Statement > WANBURY

WANBURY
Revenue

    Back to Income Statement
WANBURY is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for WANBURY
Please provide your vote to see the results

WANBURY Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹600 Cr₹578 Cr₹500 Cr₹511 Cr₹393 Cr

What is the latest Revenue of WANBURY ?

The latest Revenue ratio of WANBURY is ₹600 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹600 Cr
Mar2024₹578 Cr
Mar2023₹500 Cr
Mar2022₹511 Cr
Mar2021₹393 Cr

How is Revenue of WANBURY Trending?

Years Revenue % Change
Mar2025 ₹600 Cr
3.77
Mar2024 ₹578 Cr
15.63
Mar2023 ₹500 Cr
-2.26
Mar2022 ₹511 Cr
30.23
Mar2021 ₹393 Cr -

Compare Revenue of peers of WANBURY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WANBURY ₹831.8 Cr 0.4% -4.6% -24.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,513.0 Cr -0.1% 3.4% -0.1% Stock Analytics
DIVIS LABORATORIES ₹170,614.0 Cr 1.6% -2.5% 8.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,245.0 Cr 0.8% -0.9% 13.5% Stock Analytics
CIPLA ₹122,555.0 Cr 1.3% -0.6% 3.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,803.0 Cr 1% 3.7% 2.7% Stock Analytics


WANBURY Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WANBURY

0.4%

-4.6%

-24.6%

SENSEX

-0.5%

1%

4.6%


You may also like the below Video Courses